<?xml version="1.0" encoding="UTF-8"?>
<p id="para120">We initiated a phase 1, open-label, single-arm, dose-escalation study at the Walter Reed Army Institute for Research Clinical Trials Center (Silver Spring, MD, USA). The study was approved by the Centre's institutional review board. The 
 <xref rid="sec1" ref-type="sec">appendix</xref> is available online and contains supplemetnal data figures and tables, the clinical study protocol, and the statistical analysis plan.
</p>
